Dilated cardiomyopathy (DCM)

Dilated cardiomyopathy (DCM) is a serious heart condition characterized by weakening and dilation of the heart muscle, resulting in reduced ability of the heart to pump blood effectively throughout the body. In this disease, the muscular walls of the heart become thin and stretched, and the heart chambers enlarge significantly as the muscle loses its contractile strength. This leads to progressive heart failure as the weakened heart struggles to maintain adequate circulation. Once the most common form of heart disease in cats, the incidence of DCM decreased dramatically following the discovery that taurine deficiency was a major cause and the subsequent supplementation of commercial cat foods with adequate taurine. However, DCM still occurs in cats due to other causes, making awareness of this condition important for cat owners and veterinary professionals.

The development of DCM in cats involves progressive deterioration of the heart muscle cells (cardiomyocytes), leading to reduced contractility and compensatory dilation of the heart chambers. When the heart muscle weakens, the heart attempts to maintain output by enlarging, similar to stretching a rubber band to increase capacity. However, this compensation is ultimately counterproductive, as the stretched muscle fibers become even less efficient at contracting. The left ventricle, which pumps blood to the body, and the left atrium, which receives blood from the lungs, typically become significantly enlarged. As the disease progresses, the heart becomes increasingly unable to pump blood effectively, leading to congestive heart failure and potential life-threatening complications including blood clot formation.

The impact of DCM on a cat's health can be profound, affecting multiple body systems as inadequate blood flow compromises organ function. As the heart fails to pump effectively, blood backs up into the lungs causing pulmonary edema (fluid accumulation), or into the chest cavity causing pleural effusion. These complications cause respiratory distress, which may be the first sign that owners notice. Reduced blood flow to the kidneys may cause kidney dysfunction. The sluggish blood flow through the enlarged, poorly contracting heart chambers creates conditions favorable for blood clot formation, putting affected cats at risk for aortic thromboembolism (saddle thrombus), a devastating complication. Weakness, lethargy, and reduced appetite reflect the body's struggle to function with inadequate circulatory support.

Despite its severity, DCM is potentially manageable with appropriate treatment, and some cases caused by taurine deficiency can show significant improvement or even reversal with nutritional correction. Treatment focuses on supporting cardiac function with medications, managing the complications of heart failure, and addressing any underlying nutritional deficiency. When taurine deficiency is identified and corrected early, before irreversible damage has occurred, the prognosis can be remarkably good. For cases not related to taurine, or when significant permanent damage has occurred, the condition remains manageable for variable periods with medication, though long-term prognosis is more guarded. Early detection through recognition of subtle symptoms and regular veterinary care improves outcomes by allowing intervention before advanced heart failure develops.

The primary historical cause of dilated cardiomyopathy in cats was dietary taurine deficiency, an association that was discovered in the late 1980s and revolutionized feline cardiac health. Taurine is an essential amino acid for cats, meaning they cannot synthesize it adequately and must obtain it from their diet. Unlike most mammals, cats have a critical requirement for dietary taurine to maintain normal heart function, as taurine plays essential roles in calcium handling within heart muscle cells and maintenance of normal contractility. Before this discovery, many commercial cat foods contained inadequate taurine levels, leading to widespread DCM. Once pet food manufacturers began supplementing cat foods with appropriate taurine levels, the incidence of feline DCM declined by approximately 90 percent, representing one of the most dramatic improvements in animal health achieved through nutritional intervention.

Genetic and hereditary factors contribute to DCM in cats independent of taurine status, particularly in certain breeds. Some cats appear to have genetic predisposition to developing DCM even when receiving adequate dietary taurine. Siamese, Abyssinian, and Burmese cats have been reported to have higher incidences of DCM, suggesting breed-related genetic factors. The specific genetic mutations responsible for feline DCM have not been as well characterized as those for hypertrophic cardiomyopathy, but familial clustering of cases supports a hereditary component. Cats with family history of DCM or heart disease may carry genetic susceptibility that manifests when combined with other factors or simply with aging.

Environmental and nutritional factors beyond simple taurine deficiency may contribute to DCM development in some cats. Cats eating home-prepared diets that have not been properly balanced may develop nutritional deficiencies including taurine inadequacy. Certain cooking methods can destroy taurine in food, and diets high in certain types of fiber may impair taurine absorption. Cats with gastrointestinal disease affecting absorption may develop relative taurine deficiency despite adequate dietary intake. Additionally, some concern has emerged regarding potential associations between certain grain-free diets and DCM in dogs, though this relationship is less clear in cats. Other nutritional factors such as L-carnitine deficiency have been implicated in some cases.

Various secondary causes can lead to DCM or DCM-like heart changes in cats. Severe systemic illness, particularly conditions causing severe metabolic derangements, can adversely affect heart function. Persistent tachycardia from sustained rapid heart rhythms can cause tachycardia-induced cardiomyopathy with changes resembling DCM. Hyperthyroidism, while more commonly associated with hypertrophic changes, can occasionally lead to DCM-like presentation. Chemotherapy with certain cardiotoxic drugs can damage heart muscle. Severe anemia forcing the heart to work harder to maintain oxygen delivery may contribute to myocardial dysfunction. In many cases, despite investigation, no specific cause is identified, and the condition is classified as idiopathic DCM.

The mechanism by which taurine deficiency causes DCM involves disruption of fundamental cellular processes within heart muscle cells. Taurine is involved in regulating calcium movement within cells, and calcium is essential for muscle contraction. When taurine is deficient, calcium handling becomes abnormal, leading to impaired contractility and eventually cell damage and death. The loss of functional heart muscle cells leads to progressive weakening and dilation of the heart. Additionally, taurine has antioxidant properties, and its deficiency may increase oxidative stress on the heart. The good news is that if the deficiency is corrected before extensive permanent damage has occurred, the heart can recover substantial function as calcium handling normalizes and surviving cells regain normal contractility.

The early warning signs of dilated cardiomyopathy in cats are often subtle and easily overlooked, as cats are masters at hiding illness and early cardiac dysfunction may not significantly affect daily activities. Owners may notice very mild changes such as slightly decreased activity, occasional reluctance to play, or subtle changes in sleeping patterns. Some cats show mild weight loss or decreased appetite that may be attributed to other causes. The early stages of DCM may cause no obvious clinical signs, with the condition only detected through routine veterinary examination that reveals a heart murmur, arrhythmia, or changes noted on screening tests. This emphasizes the importance of regular veterinary visits for early detection of this potentially life-threatening condition.

Common symptoms of established DCM reflect the heart's failing ability to maintain adequate circulation and often present relatively suddenly despite the underlying disease having developed gradually. Respiratory signs are frequently the first obvious indication of problems, including rapid breathing, increased respiratory effort, open-mouth breathing, and coughing (though coughing is less common in cats with heart disease than in dogs). Lethargy and weakness become apparent as the body struggles with inadequate blood flow. Decreased or absent appetite is common. Some cats show cold extremities due to poor peripheral circulation. Weight loss, often masked by fluid retention, may become apparent. The accumulation of fluid in or around the lungs makes breathing progressively more labored.

Behavioral changes in cats with DCM reflect both the physical effects of heart failure and the general malaise associated with chronic illness. Affected cats typically become progressively less active, spending more time resting and showing reluctance to engage in normal activities such as playing, climbing, or interacting with family members. Some cats become withdrawn or seek out unusual resting spots, particularly positions that make breathing easier such as sternal recumbency with the neck extended. Changes in litter box habits may occur as cats become too weak or short of breath to access their normal facilities. Appetite changes are common, with some cats becoming anorexic while others show altered food preferences.

Physical signs that owners and veterinarians may observe in cats with DCM include rapid or labored breathing, which may be most noticeable when the cat is at rest. The cat may assume positions that ease respiratory effort, such as extending the head and neck or adopting a posture with elbows abducted. Heart sounds may be muffled if pleural effusion (fluid around the lungs) is present. The femoral pulses may feel weak due to reduced cardiac output. Pale or bluish mucous membranes (gums) indicate poor oxygenation. Abdominal distension may occur if fluid accumulates in the abdomen (ascites). Weight loss with muscle wasting may become apparent over time.

Symptom progression in DCM typically follows a course from subtle early changes to increasingly obvious signs of heart failure. Some cats experience a relatively sudden onset of crisis symptoms as the heart reaches a point of decompensation, potentially presenting in acute respiratory distress despite minimal prior signs. Others show a more gradual decline with progressively worsening exercise intolerance, respiratory symptoms, and weakness. Without treatment, the disease follows a progressive course leading to life-threatening complications. The development of pleural effusion often marks a significant worsening, as accumulated fluid compresses the lungs and severely compromises breathing.

Emergency symptoms requiring immediate veterinary attention include severe respiratory distress with labored breathing, rapid shallow breathing, or blue-tinged gums indicating oxygen deprivation. Sudden collapse or extreme weakness should prompt emergency evaluation. Signs suggestive of aortic thromboembolism, a devastating complication of DCM, include sudden paralysis of one or both hind limbs, vocalization indicating severe pain, and cold, painful legs without palpable pulses. Complete loss of appetite for more than 24 hours, especially if combined with respiratory changes or weakness, warrants urgent attention. Any cat suspected of having heart disease that shows sudden worsening of symptoms requires immediate emergency care.

The diagnostic process for dilated cardiomyopathy typically begins when a cat presents with symptoms of heart failure or when abnormalities are detected during routine examination. Physical examination findings suggestive of DCM include an abnormal heart rhythm, heart murmur, muffled heart sounds (if pleural effusion is present), abnormal lung sounds, weak pulses, and evidence of respiratory distress. The veterinarian will perform a thorough examination and gather history about the cat's symptoms, diet, and general health. Because DCM can present as a sudden crisis, initial stabilization may be needed before comprehensive diagnostics can be safely performed in cats presenting in respiratory distress.

Diagnostic testing for DCM includes several modalities that together confirm the diagnosis and assess its severity. Thoracic radiographs (chest X-rays) reveal characteristic changes including generalized heart enlargement with a rounded appearance, and evidence of congestive heart failure such as pulmonary edema or pleural effusion. Electrocardiography (ECG) may reveal arrhythmias, particularly atrial fibrillation, which is common in DCM, and changes suggesting chamber enlargement. Echocardiography (cardiac ultrasound) is the definitive diagnostic tool, allowing direct visualization of the thin, poorly contracting heart walls, dilated chambers, and measurement of cardiac function through parameters such as fractional shortening and ejection fraction. Blood tests include cardiac biomarkers such as NT-proBNP and troponin, complete blood count, chemistry panel to assess organ function, and importantly, measurement of whole blood taurine levels.

The differential diagnosis for DCM includes other conditions that may cause similar symptoms or cardiac changes. Hypertrophic cardiomyopathy (HCM), the most common feline heart disease, causes thickening rather than dilation of the heart walls but can also lead to heart failure. Restrictive cardiomyopathy and unclassified cardiomyopathies may have overlapping features. Hyperthyroidism can cause cardiac changes and should be ruled out with thyroid testing. Systemic hypertension may contribute to cardiac dysfunction. Heartworm disease, though less common in cats than dogs, can cause cardiac and respiratory signs. Pericardial disease, myocarditis, and congenital heart defects are other considerations. Echocardiography is particularly valuable for distinguishing among these conditions.

Definitive diagnosis of DCM is established through echocardiographic demonstration of the characteristic features: dilated heart chambers, particularly the left ventricle and left atrium, thin ventricular walls, and markedly reduced contractility as measured by fractional shortening or other functional parameters. Normal feline fractional shortening is typically above 30-35 percent, while cats with DCM often have values below 25 percent and frequently below 15 percent. Once DCM is confirmed, additional testing focuses on identifying underlying causes, particularly taurine deficiency. Whole blood taurine levels below 250 nmol/mL suggest deficiency, though the relationship between blood levels and cardiac status can be complex. Identification of taurine deficiency is critically important because it indicates potential for improvement with supplementation.

Emergency treatment for cats presenting in acute heart failure from DCM focuses on stabilization before addressing the underlying cardiac disease. Cats in respiratory distress require immediate intervention to improve oxygenation, including oxygen supplementation and stress reduction. If pleural effusion is present and causing significant respiratory compromise, thoracocentesis (removal of fluid from the chest cavity with a needle) may be performed emergently to relieve pressure on the lungs. Diuretics, particularly furosemide, are administered to reduce fluid accumulation. Cats in crisis require careful handling and a quiet environment, as stress can be life-threatening. Once stabilized, comprehensive treatment can be initiated.

Medical management of DCM involves multiple medications targeting different aspects of cardiac dysfunction. Positive inotropes such as pimobendan are mainstay treatments that increase the strength of heart muscle contraction while also providing vasodilation to reduce cardiac workload. Diuretics including furosemide and spironolactone help manage fluid accumulation associated with heart failure. ACE inhibitors such as enalapril or benazepril reduce the workload on the heart and help counteract neurohormonal changes associated with heart failure. Beta-blockers may be used cautiously in some cases. Antiarrhythmic medications may be necessary if significant arrhythmias such as atrial fibrillation are present. Antithrombotic therapy with clopidogrel or aspirin helps reduce the risk of blood clot formation.

Nutritional therapy is a critical component of DCM treatment, particularly in cases associated with taurine deficiency. Taurine supplementation is initiated in all cats with DCM, typically at doses of 250-500 mg orally twice daily, regardless of measured blood levels, because the potential benefit is significant and the risk is minimal. Cats with confirmed taurine deficiency may show dramatic improvement over weeks to months of supplementation, with some achieving complete normalization of cardiac function. Dietary evaluation ensures the cat's regular diet contains adequate taurine and overall nutritional balance. L-carnitine supplementation is sometimes added given its potential role in some DCM cases. Omega-3 fatty acids may provide additional cardiovascular support. Sodium restriction may be recommended for cats with fluid retention.

Supportive care addresses the overall needs of cats managing DCM. Moderate activity restriction prevents overexertion of the compromised heart while avoiding the muscle wasting that accompanies complete inactivity. Stress reduction through environmental management and gentle handling is important. Nutritional support ensures adequate caloric intake, which may require offering palatable foods or appetite stimulants if appetite is poor. Temperature regulation helps cats with compromised circulation. Monitoring of respiratory rate at home provides an important indicator of heart failure status, with increases from baseline suggesting worsening fluid accumulation. Regular weight monitoring detects fluid accumulation or continued weight loss.

Alternative and complementary approaches to DCM management have limited evidence but may be considered as adjuncts to standard therapy. Coenzyme Q10 has been studied for potential cardiac benefits given its role in cellular energy production. Omega-3 fatty acids from fish oil may have anti-arrhythmic and anti-inflammatory effects. Herbal supplements marketed for cardiac support lack clinical evidence in cats and should be approached with caution. Acupuncture has been used by some practitioners as part of integrative management. Any complementary approaches should be discussed with the veterinarian to ensure they do not interfere with essential medical treatment.

Treatment decisions in DCM consider the severity of disease, underlying cause, response to treatment, and overall quality of life. Cats with taurine-deficiency DCM that is detected before severe irreversible damage has occurred may have good long-term prognosis with nutritional correction and supportive care. Cats with idiopathic DCM or advanced disease have more guarded prognosis, with treatment focused on managing symptoms and maintaining quality of life for as long as possible. The costs of ongoing medication, monitoring, and potential emergency care must be considered. Honest discussion of realistic expectations helps owners make informed decisions about treatment intensity and goals.

The recovery timeline for cats with DCM varies dramatically depending on the underlying cause and severity of disease at diagnosis. For cats with taurine-deficiency DCM, improvement may begin within weeks of initiating supplementation, with echocardiographic parameters showing measurable improvement within three to six months. Complete or near-complete recovery of cardiac function is possible in some of these cases if treatment begins before extensive permanent damage has occurred. For cats with idiopathic DCM or those with established severe disease regardless of cause, recovery in the sense of cure is not expected, though stabilization and symptomatic improvement with treatment can significantly extend quality life.

Post-treatment care for cats with DCM involves ongoing medical management and monitoring. Medications typically require lifelong administration, with dosing adjustments based on the cat's clinical status and monitoring results. Taurine supplementation should continue indefinitely even after cardiac improvement to prevent recurrence. Home monitoring of respiratory rate provides an important early warning of decompensation; owners should count breaths per minute during rest and report increases from baseline. Activity levels should be adjusted based on the cat's tolerance, with exercise permitted but overexertion avoided. Regular veterinary visits allow assessment of clinical status and adjustment of therapy as needed.

Prognosis for cats with DCM depends on multiple factors. Cats with taurine-deficiency DCM diagnosed early, before severe congestive heart failure has developed, may have excellent prognosis with appropriate treatment, with some achieving normal life spans. Those with taurine deficiency diagnosed in advanced heart failure have more guarded prognosis, though improvement is still possible. Cats with idiopathic DCM have variable prognosis, with reported median survival times ranging from weeks to over a year depending on disease severity and response to treatment. Development of complications such as severe arrhythmias or aortic thromboembolism significantly worsens prognosis. Cats showing good response to initial treatment and maintaining stable condition on medications have better long-term outcomes.

Long-term outlook for cats living with DCM involves accepting chronic disease management while maximizing quality of life. Some cats stabilize well on medication and maintain good quality of life for extended periods, enjoying normal activities within their exercise tolerance. Others experience progressive decline despite treatment, with gradual or sudden worsening of heart failure. The risk of sudden death from arrhythmias or thromboembolic events persists regardless of apparent stability. Regular echocardiographic monitoring, typically every three to six months or as clinically indicated, tracks disease progression or improvement. Owners should be prepared for the possibility of acute decompensation and understand when to seek emergency care.

Primary prevention of dilated cardiomyopathy in cats centers largely on ensuring adequate dietary taurine intake, which has been remarkably effective in reducing the incidence of this once-common disease. Feeding a high-quality commercial cat food that meets AAFCO (Association of American Feed Control Officials) standards ensures adequate taurine levels, as all such foods are required to contain appropriate taurine supplementation. Cats eating exclusively properly formulated commercial cat food are unlikely to develop taurine-deficiency DCM. For cats eating non-traditional diets, attention to taurine content is essential. Dogs foods, which are not supplemented with taurine to the same degree as cat foods, should never be fed as a primary diet to cats.

Prevention for cats eating homemade or raw diets requires particular attention to taurine content. While raw meat naturally contains taurine, cooking destroys much of this amino acid, making cooked homemade diets risky if not properly supplemented. Cats fed homemade diets should have recipes formulated or reviewed by a veterinary nutritionist to ensure adequate taurine and other essential nutrients. Taurine supplementation may be recommended for cats on homemade diets regardless of meat content. Periodic whole blood taurine level monitoring can confirm adequate status in cats eating non-commercial diets. The convenience and safety of commercial foods makes them the preferred choice for most cat owners.

Genetic prevention in breeds with suspected hereditary DCM predisposition involves responsible breeding practices. Breeding cats from lines with known heart disease should undergo cardiac screening before breeding. While genetic testing for DCM-associated mutations is not as established in cats as testing for HCM mutations, breeders should be aware of cardiac disease in their lines. Prospective owners of breeds with DCM predisposition should inquire about cardiac health in the breeding line. Avoiding breeding affected cats helps reduce disease transmission to future generations.

Health maintenance practices support early detection of DCM before advanced disease develops. Regular veterinary examinations with cardiac auscultation can detect abnormalities prompting further investigation. Annual or semi-annual wellness visits for adult cats provide opportunity for ongoing monitoring. Cats in breeds predisposed to DCM may benefit from periodic echocardiographic screening even in the absence of clinical signs. NT-proBNP, a cardiac biomarker available as a blood test, can help identify cats warranting further cardiac evaluation. Attending to overall health through appropriate nutrition, weight management, and parasite prevention supports cardiovascular wellness.

Early intervention when risk factors or early disease are identified improves outcomes. Cats found to have low taurine levels should receive supplementation before clinical disease develops. Cats with echocardiographic abnormalities suggesting early DCM should begin treatment promptly, as early intervention with positive inotropes and appropriate support may slow disease progression. Cats with diagnosed heart disease of any type should have taurine status assessed given the potential for mixed etiologies. Working closely with a veterinary cardiologist for high-risk cats provides optimal surveillance and early intervention opportunity.

Daily management for cats with DCM involves consistent medication administration and ongoing monitoring of clinical status. Most cats require multiple medications given once or twice daily, making a regular medication schedule important for compliance. Medications are typically given with food if tolerated. Owners should monitor their cat's respiratory rate daily by counting breaths per minute during quiet rest; an increase from baseline (normal is typically less than 30 breaths per minute at rest) may indicate worsening fluid accumulation requiring veterinary attention. Appetite, activity level, and overall demeanor should be observed and significant changes noted. Litter box habits may provide clues to hydration status and overall health.

Home environment modifications support cats with compromised cardiac function. Providing easily accessible resources including food, water, litter boxes, and resting spots on a single level reduces exertion. Comfortable, quiet resting areas allow cats to conserve energy. Climate control helps cats with circulation problems maintain comfortable body temperature. Reducing environmental stressors through consistent routines, minimizing household disruption, and providing hiding spots helps maintain calm. For cats with more advanced disease or reduced mobility, resources should be within easy reach from preferred resting areas.

Maintaining quality of life is the ultimate goal of DCM management, and many cats can enjoy good quality life with appropriate care. Cats should be allowed to engage in activities they enjoy at their own pace, with forced exercise avoided. Gentle play sessions provide mental stimulation without overexertion. Social interaction with family members maintains emotional wellbeing. Comfortable rest, freedom from respiratory distress, good appetite, and ability to engage in normal behaviors indicate reasonable quality of life. When cats lose interest in food, show persistent respiratory effort, or stop engaging with their environment despite treatment, quality of life reassessment is needed.

Ongoing monitoring and regular veterinary care are essential components of managing cats with DCM. Recheck appointments typically occur every two to four months for stable cats, more frequently for unstable patients or after medication changes. Monitoring includes physical examination, chest radiographs to assess heart size and look for fluid accumulation, echocardiography to track cardiac function, and blood tests to monitor kidney function and electrolytes. NT-proBNP levels may help track disease status. Blood pressure measurement detects hypotension from medication effects. Medication adjustments are based on clinical status and monitoring results.

Caregiver support resources help owners manage the challenges of caring for a cat with chronic heart disease. Veterinary teams can provide education about the disease, medication administration, and warning signs of decompensation. Written instructions for home monitoring and emergency contacts ensure owners feel prepared. The emotional challenges of managing chronic illness in a beloved pet are real, and owners should not hesitate to express concerns or ask questions. Financial considerations for ongoing medication and monitoring costs should be discussed openly, with veterinary teams helping identify essential versus optional interventions. Understanding realistic prognosis helps owners make informed decisions about treatment goals and intensity.

Certain cat breeds appear to have elevated predisposition to dilated cardiomyopathy independent of taurine status. Siamese cats have been reported in multiple studies as having higher DCM incidence than the general cat population, though the specific genetic factors responsible have not been identified. Abyssinian cats similarly appear to be overrepresented among DCM cases. Burmese cats have been noted to have increased DCM susceptibility in some populations. These breed predispositions suggest underlying genetic factors affecting cardiac muscle development or function that manifest as DCM. However, the dramatic decrease in overall DCM incidence following taurine supplementation of cat foods demonstrates that even genetically predisposed cats may not develop disease when nutritional requirements are met.

Moderate risk factors for DCM relate to various dietary and health circumstances. Cats eating exclusively home-prepared diets, particularly cooked diets without taurine supplementation, face increased risk regardless of breed. Cats with gastrointestinal diseases affecting nutrient absorption may develop relative taurine deficiency despite adequate dietary intake. Older cats may have increased susceptibility to DCM, particularly idiopathic forms. Cats that have experienced taurine deficiency, even if subsequently corrected, may have sustained some permanent cardiac damage that predisposes to later dysfunction. Mixed breed cats can certainly develop DCM, particularly if dietary factors are involved.

Screening recommendations for at-risk breeds and individuals include regular veterinary examinations with cardiac auscultation as a minimum. For breeds with suspected DCM predisposition, periodic echocardiographic screening may be considered, particularly if any cardiac abnormalities are detected on physical examination. Measurement of whole blood taurine levels is recommended for cats eating non-traditional diets and should be considered for cats with any signs suggesting possible cardiac disease. NT-proBNP testing can serve as a screening tool for cardiac disease, with elevated levels indicating need for further evaluation. Breeders working with potentially predisposed breeds should incorporate cardiac screening into breeding programs to reduce disease transmission.

Several conditions commonly co-occur with or complicate dilated cardiomyopathy in cats. Congestive heart failure, including pulmonary edema and pleural effusion, is the most common complication as the weakened heart fails to maintain adequate circulation. Cardiac arrhythmias, particularly atrial fibrillation, frequently develop as the enlarged atria lose normal electrical function. Aortic thromboembolism (saddle thrombus) is a devastating complication as blood clots form in the dysfunctional heart and travel to obstruct peripheral arteries. Kidney disease may occur concurrently or develop secondary to reduced cardiac output. Taurine deficiency may cause retinal degeneration in addition to cardiac disease, potentially resulting in blindness.

Conditions with similar symptoms or presentation that must be differentiated from DCM include other forms of cardiomyopathy. Hypertrophic cardiomyopathy, the most common feline heart disease, causes thickening rather than dilation of the heart walls but can lead to similar symptoms of heart failure. Restrictive cardiomyopathy causes diastolic dysfunction with less obvious structural changes. Unclassified cardiomyopathy includes cases that do not fit clearly into other categories. Hyperthyroidism can cause cardiac changes and should always be ruled out in middle-aged to older cats with heart disease. Pericardial disease, myocarditis, and heartworm disease are other considerations. Echocardiography is essential for distinguishing among these conditions.

Potential complications of DCM extend beyond the primary cardiac dysfunction. Thromboembolism, occurring in approximately ten to twenty-five percent of cats with DCM, causes acute paralysis of affected limbs and carries high mortality. Progressive heart failure may become refractory to medical management despite maximal therapy. Sudden death from malignant arrhythmias can occur even in apparently stable cats. Chronic cardiac medication can affect kidney function, requiring monitoring and dose adjustments. Protein-losing enteropathy can result from chronic right-sided heart failure. Prevention of complications focuses on optimal disease management, antithrombotic therapy to reduce clot risk, and regular monitoring to detect and address problems early.